Salgado, M., Camara-Gómez, J. d. l., García-Escobar, I., Álvarez-Llosa, R., González-Villarroel, P., Fernández Garay, D., . . . Muñoz, A. (2025). Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: A randomised, clinical trial design.
Citación estilo ChicagoSalgado, Mercedes, et al. Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients With Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design. 2025.
Cita MLASalgado, Mercedes, et al. Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients With Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design. 2025.